Sign In

Carolyne Zimmermann

Vice President Transactions at J&J Innovation

Professional Background

Carolyne Zimmermann serves as the Vice President of Transactions at the Johnson & Johnson Innovation Center in San Francisco, where she spearheads a dynamic transaction team dedicated to forging and negotiating collaborations that drive value for early-stage innovators. These collaborations are focused on groundbreaking healthcare solutions that have the potential to significantly enhance human health globally.

Since joining Johnson & Johnson in mid-2016, Carolyne has made remarkable strides in her role, working in harmony with her colleagues across the Innovation Center and various business teams to close transactions valued at an impressive $2.5 billion. Her portfolio includes successful collaborations with forward-thinking companies and institutions such as Bird Rock Bio, UC San Diego, Zymeworks, and TeneoBio. This track record underscores her capacity to foster strategic partnerships that result in impactful health innovations.

Prior to her impactful tenure at Johnson & Johnson, Carolyne accumulated over 14 years of invaluable experience at Novartis Pharmaceuticals. One of her notable positions there was as a General Partner and founding member of dRx Capital, a significant $100 million digital health investment fund created in partnership with Qualcomm Ventures. In this role, she played a crucial part in driving investments in digital health initiatives, thereby contributing to Novartis's reputation as a forward-thinking leader in the pharmaceutical industry.

In addition to her work at dRx Capital, she excelled as the Head of Business Development for the Cardiovascular and Metabolic Franchise at Novartis Pharmaceuticals, where she crafted and executed external pipeline strategies. Her leadership within the Global Business Development group was instrumental, as she held several influential positions including Head of Search & Evaluation, Negotiations, and Alliance Management across a wide array of therapeutic areas. Carolyne's extensive expertise encompasses a variety of transaction types, including in-licensing, out-licensing, acquisitions, restructurings, equity investments, research collaborations, and option deals, making her a versatile player in the healthcare innovation sector.

Education and Achievements

Carolyne's academic journey laid a solid foundation for her thriving career in business development and healthcare investments. She studied for her Master of Business Administration (MBA) at Columbia University, a prestigious institution known for cultivating leaders in various industries. Her educational background is complemented by a Bachelor of Science (BS) degree from the University of California, San Diego, where she honed her analytical skills and deepened her understanding of scientific principles pivotal to the healthcare sector.

Achievements

Throughout her career, Carolyne has consistently demonstrated exceptional leadership and strategic insight. At Johnson & Johnson, her role as Vice President of Transactions has allowed her to its forefront of innovation, where she is not only involved in high-stakes negotiations but also plays a pivotal role in shaping the future of healthcare solutions.

Her accomplishments at Novartis Pharmaceuticals are equally noteworthy. As the General Partner of dRx Capital, she played a key role in establishing a unique partnership focused on investing in digital health, reflecting her vision for integrating technology with healthcare—a focus that is becoming increasingly critical in today's landscape.

Carolyne's impressive ability to navigate complex negotiations and build lasting partnerships has contributed significantly to advancing innovative healthcare solutions that serve the needs of patients worldwide. Her commitment to excellence in the field, coupled with her vast experience, makes her an influential leader poised to continue shaping the future of healthcare investment.

Tags

Vice President Transactions

Johnson & Johnson Innovation

Healthcare Solutions

Deal Making

Venture Investing

Novartis Pharmaceuticals

Digital Health Investment

Business Development

Cardiovascular Franchise

Metabolic Franchise

Executive Leadership

Global Business Development

Strategic Partnerships

Negotiations

Alliance Management

Related Questions

How did Carolyne Zimmermann develop her expertise in healthcare transactions?
What inspired Carolyne Zimmermann to focus on digital health investments?
Can you explain the impact of Carolyne Zimmermann's work at Johnson & Johnson Innovation on early-stage healthcare companies?
How has Carolyne Zimmermann's educational background influenced her career in pharmaceutical business development?
What strategies does Carolyne Zimmermann employ to foster successful collaborations in the healthcare industry?
Carolyne Zimmermann
Add to my network

Location

San Francisco Bay Area